Last update 07 Nov 2024

WO2024006961

Patent Mining

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms-
Target
IL2RA
Mechanism-
Therapeutic Areas
Immune System DiseasesNervous System DiseasesEndocrinology and Metabolic Disease+ [1]
Active Indication
Endocrinology and Metabolic DiseaseImmune System DiseasesNervous System Diseases+ [1]
Inactive Indication-
Originator Organization
Neurogene, Inc. (New York)Neurogene, Inc. (New York)StartupNeoleukin Therapeutics, Inc.Neoleukin Therapeutics, Inc.
Active Organization
Neoleukin Therapeutics, Inc.Neoleukin Therapeutics, Inc.Neurogene, Inc. (New York)Neurogene, Inc. (New York)Startup
Inactive Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WO2024006961
Login to view more data
100 Translational Medicine associated with WO2024006961
Login to view more data
100 Patents (Medical) associated with WO2024006961
Login to view more data
100 Deals associated with WO2024006961
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Endocrinology and Metabolic DiseaseDiscovery-
Neurogene, Inc. (New York)Neurogene, Inc. (New York)Startup
04 Jan 2024
Endocrinology and Metabolic DiseaseDiscovery-
Neoleukin Therapeutics, Inc.Neoleukin Therapeutics, Inc.
04 Jan 2024
Immune System DiseasesDiscovery-
Neoleukin Therapeutics, Inc.Neoleukin Therapeutics, Inc.
04 Jan 2024
Immune System DiseasesDiscovery-
Neurogene, Inc. (New York)Neurogene, Inc. (New York)Startup
04 Jan 2024
Nervous System DiseasesDiscovery-
Neurogene, Inc. (New York)Neurogene, Inc. (New York)Startup
04 Jan 2024
Nervous System DiseasesDiscovery-
Neoleukin Therapeutics, Inc.Neoleukin Therapeutics, Inc.
04 Jan 2024
Skin and Musculoskeletal DiseasesDiscovery-
Neurogene, Inc. (New York)Neurogene, Inc. (New York)Startup
04 Jan 2024
Skin and Musculoskeletal DiseasesDiscovery-
Neoleukin Therapeutics, Inc.Neoleukin Therapeutics, Inc.
04 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free